Journal
EPILEPSIA
Volume 55, Issue 8, Pages 1229-1234Publisher
WILEY
DOI: 10.1111/epi.12711
Keywords
Antiepileptic drugs; Pregnancy; Seizures; Lamotrigine; Levetiracetam; Topiramate
Categories
Funding
- Epilepsy Society of Australia
- Royal Melbourne Hospital Neuroscience Foundation
- Victorian Epilepsy Foundation
- Epilepsy Australia
- Sanofi-Aventis
- UCB Pharma
- Janssen-Cilag
- Novartis
- Sci-Gen
- National Health and Medical Research Council
Ask authors/readers for more resources
Objectives: To assess the effectiveness of the newer antiepileptic drugs (AEDs)-in particular lamotrigine, topiramate, and levetiracetam-in controlling epileptic seizures in pregnant women. Methods: Analysis of data in the Australian Register of Antiepileptic Drugs in Pregnancy concerning seizure control in 1,534 pregnancies in women with AED-treated epilepsies. Results: In AED monotherapy (1,111 pregnancies), use of levetiracetam in pregnancies in the Australian Register was associated with levels of seizure control similar to those that applied for the major older AEDs carbamazepine and valproate, but with levels of seizure control superior to those associated with use of lamotrigine and topiramate. Significance: Levetiracetam shows promise as a satisfactory drug for controlling seizures in pregnancy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available